- Report
- December 2025
- 186 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 285 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 280 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 376 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 286 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 262 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- November 2025
- 187 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- February 2025
- 185 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- August 2025
- 183 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- August 2025
- 180 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- May 2025
- 186 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- May 2025
- 185 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- April 2025
- 184 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- February 2025
- 184 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- January 2025
- 182 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- October 2025
- 144 Pages
Global
From €2264EUR$2,549USD£1,978GBP
€2664EUR$2,999USD£2,327GBP
- Report
- November 2025
- 150 Pages
Global
From €2664EUR$3,000USD£2,328GBP
€3330EUR$3,750USD£2,910GBP
- Report
- March 2025
- 145 Pages
Global
From €2264EUR$2,549USD£1,978GBP
€2664EUR$2,999USD£2,327GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €888EUR$1,000USD£776GBP
€1110EUR$1,250USD£970GBP
- Report
- February 2025
- 221 Pages
Global
From €2220EUR$2,500USD£1,940GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more